Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China
· Delayed Price · Currency is CNY 33.35
-0.53 (-1.56%)
At close: Mar 9, 2026
SHE:301258 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,991 | 2,153 | 2,959 | 3,598 | - | - | Upgrade
|
| Market Cap Growth | 33.38% | -27.24% | -17.76% | - | - | - | Upgrade
|
| Enterprise Value | 1,659 | 771 | 1,545 | 2,218 | - | - | Upgrade
|
| Last Close Price | 33.35 | 23.55 | 31.47 | 37.70 | - | - | Upgrade
|
| PE Ratio | 39.67 | 131.23 | 26.38 | 20.29 | - | - | Upgrade
|
| PS Ratio | 6.80 | 5.01 | 6.05 | 6.33 | - | - | Upgrade
|
| PB Ratio | 1.56 | 1.14 | 1.52 | 1.91 | - | - | Upgrade
|
| P/TBV Ratio | 1.62 | 1.18 | 1.54 | 1.93 | - | - | Upgrade
|
| P/FCF Ratio | - | - | 55.68 | 35.60 | - | - | Upgrade
|
| P/OCF Ratio | 42.34 | 45.74 | 31.23 | 23.80 | - | - | Upgrade
|
| EV/Sales Ratio | 3.77 | 1.80 | 3.16 | 3.90 | - | - | Upgrade
|
| EV/EBITDA Ratio | 45.78 | 19.93 | 10.38 | 10.54 | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | 16.63 | 13.97 | - | - | Upgrade
|
| EV/FCF Ratio | -17.85 | - | 29.07 | 21.95 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.04 | 0.02 | 0.01 | 0.10 | - | Upgrade
|
| Debt / FCF Ratio | - | - | 0.04 | 0.03 | 0.16 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.70 | -0.71 | -0.73 | -0.75 | -0.45 | -0.35 | Upgrade
|
| Net Debt / EBITDA Ratio | -37.42 | -34.79 | -9.52 | -6.74 | -1.83 | -1.11 | Upgrade
|
| Net Debt / FCF Ratio | 14.33 | 23.11 | -26.66 | -14.03 | -2.82 | -2.16 | Upgrade
|
| Asset Turnover | 0.21 | 0.20 | 0.23 | 0.37 | 0.59 | 0.62 | Upgrade
|
| Inventory Turnover | 2.63 | 2.23 | 2.15 | 3.29 | 4.88 | 3.86 | Upgrade
|
| Quick Ratio | 7.83 | 9.98 | 13.23 | 10.13 | 2.56 | 2.70 | Upgrade
|
| Current Ratio | 8.56 | 11.10 | 14.71 | 11.01 | 2.98 | 3.36 | Upgrade
|
| Return on Equity (ROE) | 3.99% | 0.86% | 5.85% | 13.49% | 17.61% | 23.42% | Upgrade
|
| Return on Assets (ROA) | -0.18% | -0.27% | 2.76% | 6.47% | 9.74% | 13.21% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.92% | -1.54% | 16.26% | 31.73% | 28.64% | 36.14% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.30% | -0.50% | 4.60% | 8.10% | 17.20% | 24.00% | Upgrade
|
| Earnings Yield | 2.54% | 0.76% | 3.79% | 4.93% | - | - | Upgrade
|
| FCF Yield | -3.11% | -2.71% | 1.80% | 2.81% | - | - | Upgrade
|
| Dividend Yield | 0.27% | 0.39% | 1.91% | 1.54% | - | - | Upgrade
|
| Payout Ratio | 10.88% | 335.10% | 47.39% | 20.83% | 0.36% | 71.16% | Upgrade
|
| Buyback Yield / Dilution | 1.75% | 0.88% | -6.83% | -25.31% | 0.17% | -2.00% | Upgrade
|
| Total Shareholder Return | 2.02% | 1.26% | -4.93% | -23.77% | 0.17% | -2.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.